Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
07-09 April, 2026
Health 2.0 ConferenceHealth 2.0 Conference
Not Confirmed
Not Confirmed
07-09 April, 2026
Not Confirmed
Not Confirmed
09-12 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
07-09 April, 2026
Health 2.0 ConferenceHealth 2.0 Conference
Industry Trade Show
Not Confirmed
07-09 April, 2026
Industry Trade Show
Not Confirmed
09-12 April, 2026
Digital content

06 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260106991011/en/Lysoway-Therapeutics-Announces-Phase-I-Readiness-of-Brain-Penetrant-TRPML1-Agonist-LW-1017-and-Nomination-of-a-TMEM175-Development-Candidate

05 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250805132586/en/Lysoway-Therapeutics-Awarded-Grant-from-The-Michael-J.-Fox-Foundation-to-Advance-TRPML1-Agonist-to-Treat-Parkinsons-Disease
ABOUT THIS PAGE